Clinical Trial

Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

Study acronym: BIOCLOSE-PFO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the Safety and Efficacy of a Novel Biodegradable Occluder for Percutaneous Closure of Patent Foramen Ovale (PFO)
Trial Details
NCT Number NCT07300358
Lead Sponsor Shanghai Lingsi Medical Technology Co., Ltd.
Conditions Cardiovascular Diseases, Cardiovascular Abnormality, Heart Defects, Congenital, Heart Septal Defects, Heart Septal Defects, Atrial, Foramen Ovale, Patent, Stroke, Ischemic, Stroke (CVA) or TIA
Enrollment 258 participants
Start Date 2025-12-30
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-23